Pharmacokinetic and Chemical Synthesis Optimization of a Potent d-Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery.

about

Pharmacokinetic and Chemical Synthesis Optimization of a Potent d-Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery.

Item

http://www.wikidata.org/entity/Q50046992

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacokinetic and Chemical S ...... for Extended-Release Delivery.

@en

Pharmacokinetic and Chemical S ...... for Extended-Release Delivery.

@nl

type

Item

label

Pharmacokinetic and Chemical S ...... for Extended-Release Delivery.

@en

Pharmacokinetic and Chemical S ...... for Extended-Release Delivery.

@nl

prefLabel

Pharmacokinetic and Chemical S ...... for Extended-Release Delivery.

@en

Pharmacokinetic and Chemical S ...... for Extended-Release Delivery.

@nl

P1476

Pharmacokinetic and Chemical S ...... for Extended-Release Delivery

@en

P2093

Alan L Mueller

http://www.w3.org/2001/XMLSchema#string

Brett D Welch

http://www.w3.org/2001/XMLSchema#string

Damon Papac

http://www.w3.org/2001/XMLSchema#string

Debra M Eckert

http://www.w3.org/2001/XMLSchema#string

J Nicholas Francis

http://www.w3.org/2001/XMLSchema#string

Joseph S Redman

http://www.w3.org/2001/XMLSchema#string

Robert Marquardt

http://www.w3.org/2001/XMLSchema#string

P2860

Potent D-peptide inhibitors of HIV-1 entry

Potential role of a new PEGylated recombinant factor VIII for hemophilia A.

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance

Discovering and improving novel peptide therapeutics.

Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation

Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.

Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation.

Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.

P304

1169-1179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.MOLPHARMACEUT.7B01004

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael S Kay

P577

2018-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29436835

http://www.w3.org/2001/XMLSchema#string

P932

5893306

http://www.w3.org/2001/XMLSchema#string